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ABSTRACT

Isolation of a Siderophore Produced by Methicillin-Resistant Staphylococcus aureus Strain H372
by
Rachel Presswood

Iron is necessary for many cellular processes such as the electron transport chain and gene
regulation. However, most iron on earth is found in insoluble iron-hydroxide complexes. In
addition, iron is tightly sequestered in the human body by proteins such as transferrin, making it
unavailable for pathogens. In order to overcome these limitations bacteria have evolved
siderophores. Siderophores are low molecular weight compounds that bind ferric iron with a high
affinity. Staphylococcus aureus is an important human pathogen that is known to produce at least
four siderophores, and these siderophores contribute to its virulence. S. aureus strain H372 was
found to produce a siderophore that was a carboxylate type, hydrophilic, and contained ornithine.
These properties were similar to the known siderophore staphyloferrin A. However, the probable
molecular weight was 658, which is different from known staphylococcal siderophores.
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CHAPTER 1
INTRODUCTION
Staphylococci
Staphylococci are members of a genus of Gram positive spherical bacteria. There are 33
species in this genus most of which are part of the normal flora of humans and animals. This
genus is broken down into two broad groups, the coagulase-positive staphylococci and the
coagulase-negative staphylococci (CoNS). Coagulase is an enzyme that causes blood clot
formation and is a factor in virulence. The CoNS are far less virulent than coagulase-positive
staphylococci and mainly cause opportunistic infections in the immune-compromised (24). The
primary pathogen of this genus, and the only species that is coagulase-positive, is
Staphylococcus aureus.
Staphylococcus aureus is an important human pathogen that causes many diseases
including skin infections, septic shock, and pneumonia (21). It is facultatively anaerobic, catalase
positive, and coagulase positive. Methicillin-resistant Staphylococcus aureus (MRSA) is a form
of the bacteria that can be resistant to many antibiotics including methicillin, oxacillin, penicillin,
amoxicillin, and others (16). Some MRSA strains show increased virulence as well as resistance
to additional antibiotics. A majority of all staph infections are now due to MRSA instead of
methicillin-susceptible S. aureus (MSSA) (15). There are two forms of MRSA: HealthcareAssociated MRSA (HA-MRSA) and Community-Associated MRSA (CA-MRSA).
HA-MRSA is associated with being hospitalized or having had a medical procedure
within the last year (16). Nosocomial infections increase morbidity in an already immunecompromised population, so preventing transmission is becoming a goal of all hospitals. These
infections can manifest as surgical site infections, skin infections, and pneumonias.
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Approximately 94,000 persons a year in the United States have serious, invasive MRSA
infections, and 86% of these are HA-MRSA (16). About 19,000 people a year die of MRSA (15).
HA-MRSA is also genetically distinct from CA-MRSA in its antibiotic resistance genes. Strains
of HA-MRSA contain type I, II, or III of the staphylococcal chromosomal cassette mec
(SCCmec). This mobile genetic element is capable of carrying multiple antibiotic resistance
genes across strains of S. aureus. Type I contains the mecA gene for beta-lactam resistance. Type
II and type III contain genes conferring tetracycline, erythromycin, and spectinomycin resistance
(50)
CA-MRSA occurs in persons who have not recently been hospitalized or had a medical
procedure. CA-MRSA can be spread in gyms, schools, and other places where people have close
contact. CA-MRSA often occurs in seemingly healthy people and not traditional immunecompromised populations. CA-MRSA typically manifests as skin infections such as boils.
Although CA-MRSA patients typically have a better prognosis than HA-MRSA patients, 14% of
invasive cases involve CA-MRSA and deaths have occurred (15). CA-MRSA has a type IV mec
element distinct from HA-MRSA isolates. This mec element is smaller than the ones present in
HA-MRSA and confers only beta-lactam antibiotic resistance. (59) Regardless of the type of
MRSA, antibiotic resistance is a growing public health problem, and new approaches to
treatment are needed. One area of interest is targeting iron acquisition systems of bacteria
(Torres, 2006).
Iron and Bacteria
Iron is a necessary factor for growth in the vast majority of bacteria and it is used in
numerous ways in the cell. The electron transport chain uses Fe (II)/Fe(III) redox pairs. Over 100
enzymes require iron cofactors such as heme groups or iron-sulfur clusters, and iron plays a role
11

in gene regulation (63). Actively growing bacteria generally require an intracellular
concentration of 10 -6 Molar (M) iron to perform these functions (77). For bacteria iron is
paradoxically both abundant and scarce. It is the fourth most common mineral in earth’s crust,
but in aerobic conditions and physiological pH it is bound in insoluble iron-hydroxides, (21)
causing the free iron concentration in the environment to be only 10 -18 M. Pathogenic bacteria
are also affected by the body’s sequestering of iron. Iron is under a strict homeostasis in the
human body that drops the free iron concentration to an amazingly low 10-24 M (70). This low
level is achieved by hemoglobin and other proteins that sequester approximately two-thirds of
the iron and ferritin, which stores another 30% of the body’s iron inside cells. The remaining
small percentage of iron is bound to transferrin and lactoferrin in blood and other fluids (63).
This scarcity of usable iron has driven the evolution of numerous ways for bacteria to acquire
iron such as using heme as an iron source, using transferrin as an iron source, and the use of
siderophores to sequester ferric iron and transport it back into the bacterial cell. Siderophores are
the focus of the work presented here.
Siderophores
Siderophores are low molecular weight compounds that bind ferric iron with high affinity
and they are the most common method employed in iron acquisition by bacteria. The word
siderophore is Greek for “iron carrier.” Siderophores are produced by a wide variety of
organisms including bacteria, fungi, and even some plants (63). Siderophores produced by
bacteria are the most widely studied and are the focus of my research. Siderophores undergo
complex processes of regulation, production, export, and uptake before the iron can be used by
the bacterial cell.
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Siderophores can use different types of functional groups to bind the iron, and they are
classified according to what kind of functional group is used. The most common types of
siderophores are hydroxamate and catechol types. Hydroxamate siderophores use a carboxyl
group attached to a nitrogen to chelate the iron, and catechol siderophores use hydroxyls of
catechol rings (23). Other groups include the carboxylates of which S. aureus has at least two
kinds (29).
Iron Regulation of Siderophore Production
Fur and DtxR. Iron homeostasis is a delicate balance. If iron happens to accumulate
inside the cell, the Fenton reaction creates high levels of dangerous hydroxyl radicals known as
oxidative stress. The free radicals can damage DNA and proteins ultimately killing the cell (48).
So not only must bacteria have siderophores or similar systems, but they must repress them at
times as well. Siderophores and their associated transport proteins are only produced by the
bacteria under conditions of low iron availability. Abundant iron will repress the production of
siderophores, as they are not needed, and very small amounts of iron will induce production. The
primary regulation of siderophore production and iron homeostasis in bacteria is performed at
the transcriptional level by Ferric uptake regulator (Fur) in Gram-negative and low GC-content
Gram positive bacteria and DtxR (diphtheria toxin regulator) in high GC-content Gram positives
(44). Fur is a classical repressor that uses iron(II) as a corepressor (4). It binds to the promoter
region of a siderophore operon (such as aerobactin) and prevents transcription as long as iron is
available. When iron concentration becomes low, the repression is stopped, and transcription of
siderophore biosynthesis and transport genes is allowed (4). Fur and DtxR also seem to have a
role in homeostasis of other metals including zinc and manganese (44).
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Fur in S. aureus. Staphylococcus aureus has 3 Fur homologues (Fur, PerR, and Zur) and
one DtxR homologue (MntR) contributing to its iron regulation (47). Fur is the main regulator of
iron uptake in S. aureus and it represses the genes for the fhuD2 hydroxamate uptake system and
the siderophore transport operons sirABC and sstABCD in iron-rich conditions. PerR regulates
oxidative stress resistance and iron storage. Zur is involved in zinc homeostasis. MntR regulates
manganese transport (48).
PerR in S. aureus. While Fur is the global regulator for iron in S. aureus, it is PerR that
performs most of the functions of iron homeostasis. PerR is self-regulated, manganese
responsive, iron responsive, and can repress Fur. PerR controls a wide range of genes including
the genes of catalase KatA, the alkyl hydroperoxide reductase ahpCF, the bacterioferritin
comigratory protein Bcp, the thioredoxin reductase TrxB, the ferritin Ftn, and the ferritin-like
MrgA (48). All of these genes are involved in reducing oxidative stress when iron is abundant
and need to be repressed when iron is scarce. PerR has also been shown to be necessary for
virulence in a mouse model, but its mechanism is unknown (48)
Besides Fur and DtxR there are other transcriptional regulators that sense the presence of
iron-bound siderophores. There are 4 types: alternative sigma factors, 2-component sensory
transduction systems, AraC-type regulators, and further transcriptional regulator types (63).
Alternative Sigma Factors. Sigma factors are involved in transcription of genes by
assisting the binding of RNA Polymerase to promoter regions. Different sigma factors control
different sets of genes. Bacteria often have a primary sigma factor for control of genes used for
vegetative cells in normal conditions and alternative sigma factors to activate the genes
necessary during specific situations such as heat shock, stationary phase, or starvation (40).
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Some of these alternative sigma factors are used during low iron conditions that involve
use of siderophore-mediated acquisition. Escherichia coli’s FecI sigma factor system is one of
these. The outer membrane (OM) receptor FecA interacts with a ferric dicitrate siderophore and
transmits a binding signal to FecR in the cytoplasmic membrane. FecR activates FecI. FecI then
binds to the RNA polymerase core enzyme, directs it to the fecA promoter, and initiates
transcription of the fecABCDE genes, which control transport of the ferric dicitrate siderophore
(30). There are many homologues to this system in several species including PupI-PupR-PupB
regulating pseudobactin in Pseudomonas putida and FpvI/PvdS-FpvR-FpvA regulating
pyoverdin in P.aeruginosa (9).
Two-Component Sensory Transduction Systems. Two-component signal transduction
systems are the primary way that bacteria sense and respond to extracellular signals (82). These
systems consist of a sensor histidine kinase and a response regulator substrate. After receiving
the signal, the bacteria modifies its physiology in some way including gene expression,
catalyzing reactions, and modifying protein-protein interactions (82). These systems have been
found to regulate siderophore uptake in P. aeruginosa. When iron-bound enterobactin is detected
in the periplasm, the PfeR-PfeS system induces the pfeA Fe-enterobactin receptor (28).
AraC-type Regulators. The araC-type regulators are a class of positive transcriptional
regulators in bacteria that are highly conserved and widely distributed across Gram positives,
proteobacteria, and cyanobacteria. Their 3 main regulatory functions are carbon metabolism,
stress response, and pathogenesis (36). AraC-type regulators can also function as intracellular
siderophore sensors. These regulators can respond to the presence of siderophore before export
or after uptake and this signal can help the cell “fine-tune” its siderophore synthesis (62).
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Members of this class include PchR in P. aeruginosa regulating pyochelin, AlcR in Bordetella
pertussis regulating alcaligin, and YbtA in Yersinia pestis regulating yersiniabactin (11, 31, 62).
Further transcriptional Regulators. While the majority of non-Fur iron regulators can be
placed into the above categories, there are a few unique systems that have been discovered. IrgB
is the only LysR-type regulator that has been found to have a role in iron regulation. It activates
the enterobactin receptor IrgA in Vibrio cholerae but does not interact with enterobactin itself or
other known siderophores (39). AngR is a non-ribosomal peptide synthase found in Vibrio
anguillarum that can activate the genes for anguibactin synthesis, transport, and uptake. It is
encoded in a virulence plasmid and mutations can cause hyperproduction of the anguibactin (87).
Post transcriptional Regulation. There are 2 general mechanisms of posttranscriptional
regulation of iron homeostasis in bacteria: one involving RNAs and one involving proteins
similar to those used in mammalian iron homeostasis. In some bacteria Fur-regulated antisense
RNAs cause mRNA degradation of iron-related genes. Examples include RhyB in enteric
bacteria and PrrFr1/PrrFr2 in P. aeruginosa (88). In Bacillus subtilis, however, the aconitase
CitB loses its iron cluster during oxidative stress or iron depletion and subsequently interacts
with operons that have structures similar to mammalian iron-responsive elements. This function
corresponds to the mammalian protein IRP1 (2, 74).
Siderophore Biosynthesis
Non-Ribosomal Peptide Synthases. Non-ribosomal peptide synthases (NSPS) are large
multienzyme complexes that assemble a large variety of products in the cell including many
siderophores (41). NSPS are responsible for the synthesis of aryl-capped siderophores and many
non-hydroxamate and non-catechol siderophores. The NSPS synthesis pathways of many
16

siderophores have been characterized in detail including enterobactin, yersiniabactin, pyoverdin,
vibriobactin, and mycobactin (63).
Independent of NSPS. The majority of hydroxamate and catecholate siderophores are
assembled by NSPS-independent mechanisms (63). These siderophores are often virulence
factors. There are 2 steps in the typical hydroxamate synthesis: N-hydroxylation and formylation
or acylation of the hydroxylated amine. The N-hydroxylation is catalyzed by flavin adenine
dinucleotide (FAD)-dependent monooxygenases. One oxygen atom may be transferred to lysine,
ornithine, cadaverine, putrescine, or other similar amino acids (19, 89). The acylation step (more
common than formylation) is catalyzed by acyl coenzyme A transferases. Substrates are carboxy
acids such as acetate, succinate, B-hydroxybutyrate, or decenoate. The final step in NSPSindependent siderophore synthesis is catalyzed by IucA and/or IucC-type siderophore synthases.
These enzymes were discovered in the synthesis of aerobactin, and all known NSPS-independent
pathways use at least one enzyme that is very similar to these (19).
Siderophore Export
Few siderophore export systems are known in bacteria; however, the known types fall
into the categories of types of efflux pumps: the major facilitator superfamily (MFS), resistance,
nodulation, cell division superfamily (RND), and the ATP-binding cassette superfamily (ABC)
(63).
MFS. The MFS superfamily is a group of transporters that carry out uniport, symport,
and antiport transport of many compounds including drugs, primary metabolites,
neurotransmitters, and anions. They also perform both siderophore efflux and uptake (76). One
of the best studied of these MFS proteins is EntS in E. coli, which is involved in enterobactin
17

export. EntS has 12 trans-membrane segments and is regulated by Fur. EntS is responsible for
export across the cytoplasmic membrane (CM), but another protein, TolC, is required for
transport across the OM (7, 35). EntS mutants do not export enterobactin but do release its
byproducts. Because of this it is hypothesized that many other unknown proteins must be
involved in export. Besides E coli, many other bacteria have transporters with high similarity to
EntS including LbtB in Legionella pneumophila (3).
RND. The RND superfamily is a group of transporters that use proton antiport
mechanisms to perform efflux of heavy metals, drugs, lipids, and siderophores (66). The MexAMexB-OprM system in Pseudomonas aeruginosa is thought to be an RND-type transporter
involved in the export of the siderophore pyoverdin (69). The Mex operon is iron-regulated and
pyoverdin has a similar structure to other molecules exported by this system, but mutant data are
not available to fully elucidate its role in export (54). RND transporter systems as well as MFS
systems are ubiquitous across all three kingdoms of life, so it is likely that siderophore export
will be found to involve many of these types of systems (63).
ABC. ABC-type transporters are involved in both uptake and efflux of siderophores and
numerous other substrates. These transporters have 2 integral membrane domains and 2
cytoplasmic membrane domains for ATP binding and hydrolysis (8). The models proposed for
the transport of the substrate include movement of the subunit halves (71), domain swapping
(27), and a conformational change in the trans-membrane segments to allow the substrate to pass
through (49, 57, 63). Some mutants of these transporters do not accumulate siderophore
intracellularly, indicating that the processes of synthesis and export are linked in some way. This
appears to be the case only when NRPS synthesis is employed (35, 91).
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Examples of siderophores with ABC transport systems include exochelin in mycobacteria
and salmochelins in Salmonella (55).
Siderophore Uptake
After siderophores have been synthesized, secreted, and have bound with iron, the
bacteria must then bring that iron back into the cell to use it. Some bacteria have membranebound reductases that reduce the iron, which is then taken up as an ion, but most bacteria
internalize the entire siderophore complex. The transport systems for iron-bound siderophores
are well studied and diverse. Many bacteria produce more than one type of siderophore
transporter because they have evolved uptake mechanisms for xenosiderophores, siderophores
that are produced by other species and strains of bacteria (63).
Gram Negative. Siderophores of Gram negative bacteria have complex transport
mechanisms involving an outer membrane receptor, periplasmic proteins, and an ABC
transporter in the cytoplasmic membrane. Many of the Gram negative transport systems show
marked similarities. FecA, FhuA, FepA, FpvA, and FptA are OM receptors found in E. coli or P.
aeruginosa. All have a beta barrel structure at the C-terminus and N-terminal residues that form
a plug (18). When a siderophore binds, the plug residues presumably undergo a conformational
change and create a channel (17). The process of transport is mediated by the TonB complex,
which presumably supplies energy. TonB is anchored in the CM, spans the periplasm, interacts
with the OM receptor, and contacts 2 CM-embedded proteins, ExbB and ExbD (45). It is thought
that the TonB complex tranduces proton motive force energy to the OM receptor to allow
transport of the siderophore complex (45).
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After transport into the periplasm, the siderophore must be further transported into the
cytoplasm. In Gram negative bacteria this is accomplished with the use of periplasmic binding
proteins. These proteins bind the Fe-siderophore complex and interact with transmembrane
permeases to allow the complex to be channeled through the CM. Energy is supplied by ABC
subunits in the cytoplasm that dimerize and undergo conformational changes when ATP binds
(51).
Gram Positive. While Gram negative siderophore systems are well-studied, much less
data are available concerning all aspects of Gram positive siderophores including those of S.
aureus, the focus of this research (13). However, because transport is so tied to the OM and
periplasm in Gram negatives, differences in transport have been studied and a few things are
known about Gram positives. Because Gram positives lack an OM and a periplasm, siderophore
complexes only need to cross the CM. Lipoproteins on the outside surface of the CM take the
place of periplasmic binding proteins and OM receptors (85). Because of the lack of a periplasm,
the functions of extracellular binding, transmembrane channeling, and cytoplasmic ATP
hydrolysis are often fused into a single ABC transporter such as IrtA in M. tuberculosis (72).
Release of Iron
As mentioned previously, iron may be reduced extracellularly by ferric-chelate
reductases and taken up by the cell or the iron-siderophore complex may be transported across
the membrane. If the entire siderophore complex is taken up, intracellular ferric-siderophore
reductases or ferric-siderophore hydrolases are used to free the iron (68). The use of reductases
appears to be more common and is a non-specific adaptation of established reductase activities
(43). The intact siderophore left after iron is removed could potentially be reused. The use of
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hydrolases is siderophore specific and appears to be more costly for the cell due to the
degradation of the siderophore (63). After iron is released into the cytoplasm, it can be used
immediately or be stored in a protein such as bacterioferritin (14)
Staphylococcal Siderophores and Virulence
While siderophores are important for all bacteria, the processes of mutation and
horizontal transport have endowed some bacteria with better siderophore systems than others,
and this can have consequences for virulence. In S. aureus, greater production of siderophore
(nonspecifically measured by the CAS assay) is correlated with virulence in the form of higher
bacterial counts in infected mice, larger abcesses, and more inflammation (75). Strains with
higher siderophore production have also been found to be more resistant to the activity of
neutrophils in vitro (75). The uncharacterized siderophore Staphylobactin has also been shown to
be an important virulence factor that separates the highly pathogenic coagulase positive from the
more opportunistic coagulase-negative staphylococci (CoNS) (24). Mutants that cannot produce
staphylobactin are unable to persist in vivo in a mouse model. This suggests that non-siderophore
iron sources such as heme or transferrin may be important in the early stages of infection, and
siderophores are important in later stages of infection (24).
Virulence in Other Bacteria
Siderophores are essential for virulence in a wide range of bacteria and contribute to
virulence in many ways. In the case of Bordetella pertussis its siderophore alcaligin is important
in the establishment of infection. Mutant strains that did not produce the alcaligin transporter
were avirulent in a mouse model and strains with reduced expression of the transporter took
several more days to colonize mice than the wild-type (12). Siderophores are also known to be
21

significant virulence factors in the enterobacteria. The majority of enterobacteria can produce
enterobactin, some produce aerobactin, and very few produce yersiniabactin. Aerobactin and
yersiniabactin are correlated with virulence. In Klebsiella pneumoniae, mutants that cannot make
yersiniabactin have greatly reduced growth in vivo in the lungs, reduced lethality, and a reduced
ability to spread systemically. Aerobactin mutants of K. pneumoniae have a reduced ability to
cause intraperitoneal infections, showing that types of siderophores are important in determining
which sites strains can colonize (53). While most siderophores are used simply to acquire iron in
the establishment or persistence of the infection, some siderophores also have a role in evading
the immune system. Bacillus anthracis produces bacillibactin and petrobactin, which are both
efficient at binding iron. However, bacillobactin is easily bound by siderocalin, but petrobactin is
not due to its unusual 3.4-dihydroxybenzoate structure. Thus, the production of petrobactin
seems to be defensive in nature, as bacillobactin would be sufficient for iron acquisition if
siderocalin were not present (1).
Siderocalin
The majority of the human immune response to siderophores is to tightly sequester iron
in proteins such as transferrin; however, there is one direct means of defense against
siderophores, siderocalin. Siderocalin is a member of the lipocalin family and is a part of the
innate immune system (38). Siderocalin has been shown to bind enterobactin, bacillibactin,
carboxymycobactins, and parabactin (1, 46).
However, bacteria are masters at avoiding immune responses including siderocalin.
Mycobacteria usually colonize intracellular compartments of macrophages, which protects their
siderophores and allows them to exploit iron-transferrin uptake inside phagosomes (58). Some
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bacteria that produce siderophores that can be bound by siderocalin occupy niches such as
intestinal sites where they are protected from the siderocalin in the serum. And of course, many
bacteria produce siderophores that cannot be bound by siderocalin (1).
Tear Lipocalin. Tear lipocalin (Tlc) is another human protein with siderophore binding
capability. It is found in many secretory tissues and glands including tears. Tlc has a deeper,
more hydrophobic binding pocket than siderocalin and is capable of binding a wide range of
lipid products as well as siderophores (10). Tlc can bind catecholates, hydroxamates, and mixed
citrate-hydroxamate siderophores including enterobactin, desferrioxamine B, coprogen,
ferrichrome, and aerobactin (34). However, the strength of this binding is relatively low and is
not influenced by the amount of iron carried by the siderophore. Because of this, the effect of Tlc
may not be significant when binding bacterial siderophores, which can have extremely high iron
affinity. It may be important in binding the less efficient fungal siderophores (34).
Siderophores as Drug Targets
Siderophores are a potential target for antibiotics because stopping the acquisition of iron
can severely restrict growth. Inhibition of siderophore biosynthesis has been effective in
reducing in vitro growth of Mycobacterium tuberculosis (84). A bisubstrate inhibitor was used to
block the MbtA enzyme. MbtA is important in the second step of mycobactin synthesis, which is
the incorporation of salicylic acid into the core scaffold of mycobactin. Inhibiting this specific
step could be useful in other species that also use aryl-capped siderophores (84). Siderophoreantibiotic conjugates are also a promising potential development in treatment of infections.
Siderophore-antibiotic conjugates enter the bacterial cell through the specific receptors for the
siderophore, thus bypassing any efflux pumps that would normally remove the antibiotic and
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foster resistance. The conjugates would also accumulate quickly in the cell due to active
transport. This has been demonstrated in E. coli with a siderophore-carbacephalosporin
conjugate (64). Mixed-ligand siderophore-antibiotic conjugates enter through multiple outer
membrane receptors, possibly accumulating faster in the cell, and lowering the possibility that
bacteria could gain resistance to this antibiotic delivery method (37).
S. aureus and Iron
Although S. aureus has an intrinsically low requirement for iron, (56) it has evolved
many iron acquisition mechanisms including usage of heme as an iron source, direct acquisition
of iron from transferrin, and siderophores. It is the only known organism with all three of these
iron acquisition systems (67).
Heme
Heme is the preferred iron source of S. aureus (81). Hemoproteins such as hemoglobin
and myoglobin account for 80% of the iron in the human body. While siderophores are important
in persistence of infections, (24) heme usage is important in initiation of infection (81). Mutating
essential elements of the heme uptake system causes severely reduced virulence in infections of
C. elegans and murine models (81).
The main components of the heme uptake system are iron-regulated surface determinant
(Isd) proteins. The system consists of many components including cell wall anchored proteins,
membrane transporters, a transpeptidase, cytoplasmic heme-degrading monooxygenases, and a
sortase (86). The mechanism is thought to be that S. aureus lyses erythrocytes to release the
hemoglobin, binds hemoglobin with IsdB, removes the heme cofactor, transports the heme into
the cytoplasm, and then degrades it with monooxygenases (86).
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Transferrin
Although transferrin accounts for only 1% of the iron in the human body, (81) it can still
be an important source of iron for S. aureus. Staphylococcus aureus is unique in this ability, as
the only other known users of transferrin-bound iron are the non-siderophore producing
Hemophilus and Neisseria (67). Although some surface proteins such as IsdA (a component of
the heme system) can bind to transferrin, the main method of iron acquisition from transferrin is
through siderophores (67). While some siderophores use proteases to liberate iron from
transferrin, this does not seem to be the case in S. aureus (67). In some studies it has been
reported that the siderophore staphyloferrin A can remove iron from transferrin (65).
Siderophores in S. aureus
Staphylococcus aureus is known to produce at least 4 siderophores: staphyloferrin A,
staphyloferrin B, aureochelin, and staphylobactin. Staphyloferrin A and B are carboxylate type
siderophores that are similar in structure. Staphylobactin is a hydroxamate type and aureochelin
is a catechol type; however, their structures have not yet been published (90).
Staphyloferrin A. Staphyloferrin A was the first siderophore isolated from staphylococci.
Staphyloferrin A is a carboxylate type of siderophore, consisting of one ornithine and 2 citric
acid residues linked by 2 amide bonds (52) (Fig. 1). It is highly hydrophilic and has a molecular
weight of 481 Daltons (Da) (22, 61). Staphyloferrin A was first isolated from S. hyicus DSM
20459, which was the only strain able to produce it when grown in the steel stirred tank reactor
used. Other strains of staphylococci used in the Meiwes study needed a lower iron concentration
to induce its production than was possible to obtain in the steel reactor (61). However,
staphyloferrin A has been detected in S. aureus and many other species of staphylococci. The
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production of Staphyloferrin A is increased up to 19 times in some strains with the addition of Dornithine (52). While not all strains produce staphyloferrin A, and most need supplementation to
do so, all 37 strains in Meiwes study were able to use staphyloferrin A, indicating that the
transport system is widespread (61). Genetic information concerning the synthesis and transport
of staphyloferrin A has also been elucidated. The sfnaABCD gene cluster codes for
staphyloferrin A biosynthesis. Staphyloferrin A is synthesized independent of the non-ribosomal
peptide synthase pathway (NIS) using sfaB and sfaD. SfaD form a citryl-D-ornithine
intermediate and sfaB condenses the second citric acid onto the intermediate. SfaC racemases Lornithine to the D-ornithine needed in the molecule (21). The htsABC operon has been
implicated in both heme transport and staphyloferrin A transport (6).

Figure 1: Structure of Staphyloferrin A (52)
Staphyloferrin B. Like staphyloferrin A, staphyloferrin B is a carboxylate type
siderophore that was first isolated from S. hyicus DSM 20459 (61) (Fig. 2). It is highly
hydrophilic and has a molecular weight of 448 Da. Staphyloferrin B is produced by a wide
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variety of strains of staphylococci both pathogenic and non-pathogenic (42). The yield of
staphyloferrin B is increased 2.5 times when L-2,3 diaminopropionic acid is added. (29)
However, in contrast to staphyloferrin A where D-ornithine supplementation is necessary for
approximately 70% strains to produce any detectable staphyloferrin A, staphyloferrin B was
detectably produced without supplementation by approximately 90% of the strains used (61).
The biosynthesis of staphyloferrin B is thought to be by the NIS pathway and controlled by the
sbn operon (20). The sbn operon was previously associated with staphylobactin (24). The
staphyloferrin B synthesis operon of Ralstonia solacearum is similar to the sbn operon in S.
aureus (7). However, the sbn operon has not been reported in any coagulase-negative
staphylococci (CoNS), while staphyloferrin B production has been reported (6, 29, 61).
Transport of staphyloferrin B is thought to be performed by the SirABC operon (5)

Figure 2: Structure of Staphyloferrin B (42)
Staphylobactin. Staphylobactin was discovered when researchers studied siderophores
and virulence in S. aureus. In a mouse kidney model of infection strains that produced
siderophores showed increased virulence over the coagulase-negative staphylococci (CoNS) that
did not (24). An operon termed sbn was found to be responsible for the siderophore detected in
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the study. Mutants of sbnE were found to be avirulent due to lack of siderophore production.
Because the siderophore was not able to be isolated using the published procedures for
Staphyloferrin A and B and ESI-MS results were not consistent with the staphyloferrins, the
siderophore was tentatively named staphylobactin (24). Staphylobactin was extracted using a
method originally designed for the extraction of ornibactin siderophores in Burkholderia cepacia
(26, 83). Staphylobactin was later found to be a hydroxamate siderophore with citric acid
residues (90). An ABC transporter for staphylobactin has been described. The sirABC operon is
transcribed in the opposite direction of the sbn operon, which is known to code for the
biosynthetic genes of staphylobactin. SirA is a lipoprotein and sirB and sirC likely code for the
transmembrane domains of the transporter. Mutants of sirA or sirB are compromised in the
ability to uptake staphylobactin-iron complexes but not other complexes such as ferric citrate,
ferric enterobactin, or ferric hydroxamates (24).
Aureochelin. Aureochelin is a phenolate-catecholate siderophore with a molecular weight
of 577 Da (22). Its structure is currently unknown. Aureochelin was extracted using an ethyl
acetate extraction method originally used for catechol siderophores of E. coli (73). Although no
transport protein for aureochelin has yet been found, 2 iron repressible proteins of 120 and 88 Da
were found to correlate with aureochelin production in high and low siderophore producing
strains. This relationship was variable, however, prompting the authors to speculate that plasmids
may be involved. These iron repressible proteins are also antigenic, as evidenced by
immunoblotting using serum from rabbits injected with S. aureus and human serum from
septicemia patients. Healthy donor serum showed no reaction to the proteins (22).
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Hydroxamate Uptake System in S. aureus
S. aureus had been shown to be able to use the exogenous siderophores ferrichrome,
aerobactin, desferal, (77, 78) and actinoferrin (90). The hydroxamate uptake system consists of
the fhuCBG operon and proteins fhuD1 and fhuD2. These show homology to the uptake system
of Bacillus subtilis (78). FhuC codes for an ATP-binding protein, while fhuB and fhuG are
highly hydrophobic and membrane-bound (13). This operon is unusual due to it containing only
the membrane spanning and ATPase functions of a classical traffic ATPase but no receptor.
FhuD1 and fhuD2 are genes outside of the fhuCBG operon that were found to code for
lipoprotein receptors (78). FhuD2 is involved in the transport of ferrichrome, ferrioxamine B,
aerobactin, and coprogen. FhuD1 only transported ferrichrome and ferrioxamine B in this study.
It is unclear why these receptors have overlapping substrate range or why they are separate from
the overall fhu operon (78).
FhuD2’s structure and transport properties have been well-studied. Mutagenesis studies
showed several residues critical for binding and transport of iron-hydroxamates. Specifically,
Tyr-191, Trp-197, and Glu-202 are necessary for ligand binding (79). Iron-hydroxamate
transport was impaired by mutagenesis in residues Glu-97 and Glu-231. Residues for
mutagenesis were chosen based on conserved regions seen in other Gram-positive bacteria such
as Clostridium acetobutylicum, Streptococcus pyogenes, Bacillus halodurans, and Bacillus
subtilis. FhuD2 was not shown to undergo a conformational change upon binding, making it
significantly different than other known transport systems (79).
FhuD1 is a receptor that is similar in structure and sequence to fhuD2 albeit with a
narrower siderophore range (78). In contrast to the highly conserved fhuCBG and fhuD2, fhuD1
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is not present in all S.aureus strains and its location is variable. FhuD1 binds ferrichrome,
desferal, and coprogen with a slightly lower affinity than fhuD2 and does not bind aerobactin at
all. However, binding affinity did not correlate with growth promotion. Knockout mutants of
FhuD2 were still not able to uptake coprogen or aerobactin, and they required high amounts of
ferrichrome and desferal to grow. It is hypothesized that fhuD1 is a duplication of fhuD2 and it is
unknown if there are conditions where its presence confers a selective advantage (80). The entire
fhu system is regulated by Fur (80).
Present Work
The purpose of this study was to determine if strains of S. aureus produced siderophores
and what siderophore(s) they produced. Strains of S. aureus were obtained from Dr. Sanjay
Shukla at the Marshfield Clinic in Wisconsin. These strains were screened for siderophore
production and all were positive. Strain H372 was chosen for further purification due to its high
siderophore production. Growth conditions were optimized for siderophore production, and
manual column chromatography and high pressure liquid chromatography (HPLC) were used to
purify the siderophore for chemical characterization.
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CHAPTER 2
MATERIALS AND METHODS
Bacterial Strains and Characteristics
Samples of MRSA (methicillin-resistant S. aureus) were received on blood plates from
Dr. Sanjay Shukla at the Marshfield Clinic in Wisconsin. Antibiotic resistance information was
also sent with the cultures, as seen in Table 1. The strain used in this study was H372.
Table 1: Marshfield clinic Heathcare-associated (HA-MRSA) Strains. Received November 13,
2007.

HA-MRSA
Strain
004
006
008
009
012
015
025
027
032
151
161
162
167
168
174
175
176
181
182
183
251
273
282

Antibiotic Profile
Cip
Ra
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R

1

2

Ery
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
S
R
S

Cli3
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
S
S
S

Tet4
Sb
S
S
S
S
S
S
S
S
S
R
R
R
R
R
R
R
Id
R
R
S
S
S
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Sxt5
R
S
R
S
S
S
R
S
S
R
S
S
S
S
S
S
S
R
R
S
S
S
S

Gen6
Nc
N
N
N
N
N
N
N
N
N
N
R
R
R
R
R
R
N
R
R
N
N
N

Rif7
N
N
N
N
N
N
N
N
N
N
N
R
R
R
R
R
R
N
S
R
N
N
N

Table 1 (Continued)

323
R
R
R
S
S
S
R
328
R
R
R
S
S
S
S
330
R
R
R
R
R
R
S
331
R
R
S
S
S
S
S
333
R
R
R
S
S
S
S
344
R
R
R
S
S
S
S
346
R
R
S
S
S
S
S
347
R
R
R
S
S
S
S
350
R
R
S
S
S
S
S
354
R
R
R
R
R
R
R
370
R
R
R
S
S
S
S
372
R
R
S
S
S
S
S
377
R
R
S
S
S
S
S
388
R
R
R
S
S
S
S
413
R
R
R
S
S
S
S
418
R
R
S
S
S
S
S
421
R
R
S
S
S
S
S
1. Ciprofloxacin 2. Erythromycin 3. Clindamycin 4. Tetracycline 5. Sulfamethoxazole
6.Gentamycin 7.Rifampin
a. Resistant b.Susceptible c.Not tested d.Intermediate
Glycerol Stocks
Glycerol stocks of all strains were prepared by growing the bacteria in Luria-Bertani
(LB) broth for 3 to 4 hours (until OD was 0.5) and adding 0.8 mL of culture to 0.2 mL of sterile
75% glycerol. These were stored at -80 C.
Hemolysis
Hemolysis was measured by spotting bacterial cultures onto blood agar plates and
observing the clearing of blood cells on the media. Beta hemolysis was noted as clear halos of
lysed cells around the inoculum.
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Heme Testing
Testing for the usage of hemin was performed by observing a growth halo around a paper
disc impregnated with 10 μl hemin. Three milliliters of nutrient agar with 300 μm dipyridyl was
mixed with 100 μl of a 24-hour culture of MRSA and poured into a small plate. The hemin disc
was placed in the middle of the plate. After 24 hours the halo of growth around the disc was
measured.
Growth and Siderophore Production
Growth Conditions
Strains were grown in LB Broth with 500 μm dipyridyl. The cultures were grown at 37 C
on a shaker for 24 hours. The cultures were then centrifuged at 10,000 rpm for 15 minutes and
the supernatant collected.
Determination of Siderophore Production
Siderophore production was determined by the use of CAS media. Chrom Azurol S is a
dye that appears blue when complexed with ferric iron. When the iron is removed, the CAS turns
yellow. This is a universal assay for the presence of siderophores, although it gives no chemical
or structural information.
Supernatant or purified samples were added to wells cut in CAS agar plates and the
formation of yellow halos indicated the presence of siderophore. Depending on the concentration
of siderophore and the temperature halo formation could occur in as little as 30 minutes or take
up to 4 hours.

33

Purification
For purification of the siderophore a large volume of culture was needed. Batch cultures
of 4-5 liters were grown in LB broth with 500 μm dipyridyl for 24 hours at 37 C on a rotary
shaker. The seed inoculum was 10 mL of culture, and 1 mL of erythromycin (concentration 1 mg
per 1 mL) was added to prevent contamination. After incubation the cultures were centrifuged at
10,000 rpm for 15 minutes, and the supernatant was collected. To reduce the siderophore’s
solubility in water the supernatant was acidified to pH 2.00.
Manual Column Chromatography
Amberlite XAD-2. XAD-2 binds cyclic compounds, and it was the first step in
purification. The column was prepared by suspending approximately 100 g of the resin in ddH 20,
and allowing it to sit and expand overnight. The XAD mixture was deaerated, packed into the
column, and equilibrated with ddH20. The acidified supernatant was passed through the column,
and the filtrate was collected. The filtrate was checked on CAS media to ascertain if the
siderophore was bound in the column. After all the supernatant and several bed volumes of
ddH20 are passed through, methanol is used to elute the substances bound in the column.
Approximately 50 fractions are collected using a fraction collector. The fractions are checked on
CAS media to determine siderophore presence. The positive fractions are pooled and
concentrated by evaporation.
Sephadex LH-20. Sephadex LH-20 separates molecules based on both size and
hydrophobicity. The column was prepared by adding 20 g of the sephadex LH-20 to ddH20,
deaerating it, and packing it in the column. The column was equilibrated with ddH20, and the
sample was loaded. The column was run with ddH20 and fractions were collected using a
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fraction collector. The fractions were tested with CAS media, and those testing positive were
pooled and concentrated.
HPLC
HPLC was performed using a Watters 7.8 mm by 300 mm C-18 column with 0.1%
Trifluoroacetic acid (TFA) as solvent A and 0.1% TFA/Acetonitrile as solvent B. Both solvents
were filtered and deaerated before use. A program was created that equilibrated the column with
15 mL of solvent A, then slowly added solvent B in a gradient until it reached 100% over the
span of 60 minutes, then finished with 10 mL of solvent B. The sample was injected (generally
0.5 mL) and the program was started. The fractions were tested on CAS for siderophore activity.
The positive results were used to refine the gradient until it was determined that the siderophore
eluted at 23% of solvent B. The samples from each of these runs were collected and concentrated
by evaporation. When only one peak on the chromatogram was evident, the sample was
considered pure.
Characterization
Atkin’s Test
After determining siderophore production the next step is to determine siderophore type.
A positive Atkin’s Test indicates a hydroxamate siderophore. Culture supernatant (0.5 mL) is
added to 2.5 mL of iron-perchlorate reagent (5 mM Fe(ClO ) in 0.1M HClO ) and absorbance is
4 3

4

measured after 5 minutes of incubation at room temperature. The formation of a red color
indicates the presence of hydroxamic acids. Absorbance is measured at 480 nm with sterile
media as the blank.
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Arnow’s Test
The Arnow’s test detects catechol siderophores. A mixture of 1mL supernantant, 1 mL
0.5 M HCl, 1 mL of 1M NaOH, and 1 mL of Nitrite-molybdenate reagent (10 g sodium nitrite
and 10g sodium molybdate in 100 mL ddH20) is used. After 5 minutes of incubation at room
temperature, a red color will form if catechol groups are present. Absorbance is measured at
500nm with sterile media as a blank.
Amino acid Analysis
Siderophores are often conjugates of amino acids. For example both Staphyloferrin A and
B contain ornithine. For this reason amino acid analysis was performed. It was necessary to
hydrolyze the sample for amino acid analysis. The sample was hydrolyzed by adding an equal
volume of 6M HCl and autoclaving at 121 C for 6 hours. Amino acid standards were prepared by
adding 1 mg/mL of the amino acid to ddh20. Standards of all 20 protein-building amino acids
plus ornithine were made. The neutralized, hydrolyzed sample and the amino acids standards
were spotted on TLC plates (approximately 5μL each) and a solvent system of n-propanol/ddH20
in a 70:30 ratio was used to develop the TLC plate,
ESMS
The post-HPLC purified samples were divided into 2 vials and one was complexed with
iron. These were given to the Analytical Dividion of Eastman Chemical for electrospray mass
spectrometry (ESMS) analysis. A Varian Monochrom 3 column (C18 50 x 2.0 mm, PN
A040005oX020) was used with solvent A being deionized water with 260 mg ammonium
acetate and solvent B was methanol. The sample was dissolved in approximately 200 μl of

36

methanol, and 5 μl was injected at a temperature of 35 C. The ESMS was performed at 10, +25, 25, +75, and -75 volts.
NMR
The sample was also analyzed with 1D 1H Nuclear Magnetic Resonance (NMR). The
sample was dissolved in 1mL of methanol-d4. A JEOL Eclipse 600 MHz NMR spectrometer
with a 5mm OD NMR tube was used for the analysis.
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CHAPTER 3
RESULTS
The Marshfield Clinic in Wisconsin initially sent 40 strains of HA-MRSA to our lab. All
of these strains (listed in Table 1) were screened for siderophore production with the CAS assay,
and all were positive. However, the amount of siderophore production varied as evidenced by
differing sizes and brightness of the halos on the CAS plate. Strain H372 had one of the largest
and brightest halos, so it was chosen for further study.
S. aureus Strain H372 Characteristics
In the course of researching the siderophore produced by strain H372, many
characteristics of this strain were observed. These are summarized in Table 2 and discussed
further below.
Table 2: Characteristics of S. aureus H372
S. aureus Strain H372
Siderophore Production
Hemolysis
Arnow’s test
Atkins’ test
Heme
Antibiotic Profile
Ciprofloxacin
Erythromycin
Clindamycin
Tetracycline
Sulfamethoxazole
Gentamycin
Rifampin

CAS diameter 14mm
Beta
Negative
Negative
12mm halo of growth
R
R
S
S
S
S
R

Siderophore Production by S. aureus Strain H372
The CAS assay was used to determine if strain H372 produced a siderophore. The
bacteria were grown in LB broth with 500 μm dipyridyl for 24 hours and centrifuged. The
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supernatant was then placed into wells on the CAS plate, and a yellow halo indicated siderophore
production (Figure 3). The size and relative brightness indicated the amount and iron-chelating
strength of the siderophore. Strain H372 did not produce siderophore in LB broth, TMS media,
or Congo Red but did produce siderophore in LB broth with dipyridyl to sequester the ferrous
iron. The optimum amount of dipyridyl and incubation time for siderophore production were
determined to be 24 hours in LB broth with 500 μm dipyridyl. These results are summarized in
Tables 3 and 4.

Figure 3: An example of an H372 halo on CAS media
Table 3: Growth rates and siderophore production in different concentrations of LB Broth +
Dipyridyl.
Media
LB Broth
LB Broth + 250 μm dipyridyl
LB Broth + 500 μm dipyridyl
LB Broth + 750 μm dipyridyl
LB Broth +1000 μm dipyridyl

Growth at 24 hr (OD at 600 nm)
2.05
1.78
1.61
1.49
1.30
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Siderophore Production on CAS
No halo
10mm halo (light)
14mm halo (bright)
14mm halo (medium)
12mm halo (medium)

Table 4: Growth and siderophore production of H372 at different times in LB Broth + 500 μm
dipyridyl.
Time
12 hours
18 hours
24 hours
30 hours
36 hours
48 hours

Growth (OD at 600 nm)
1.23
1.37
1.64
1.58
1.53
1.47

Siderophore Production on CAS
9mm halo (Very light)
10 mm halo (medium)
14mm halo (bright)
14mm halo (bright)
12 mm halo (medium)
12mm halo (medium)

Hemolysis
Hemolysis correlates with virulence, so H372 was inoculated on a blood agar plate.
Strain H372 was beta-hemolytic, meaning that it fully cleared the red blood cells around it on the
plate (Figure 4).

Figure 4: Examples of hemolysis on a blood agar plate
Heme Usage
Heme is the preferred source of iron for S. aureus (24), so the heme usage of strain H372
was determined experimentally. Strain H372 was inoculated onto agar containing dipyridyl, and
a disc impregnated with hemin was placed on the agar. A ring of growth around the hemin disc
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indicated usage of heme as an iron source. The diameter of the ring in H372 was 12 mm,
indicating that it did have the ability to use heme.
Siderophore Purification
After the growth conditions for the optimum production of siderophore were determined,
H372 was grown in large batch cultures of 4-5 L for purification. After checking for siderophore
production on CAS, the broth was centrifuged. The supernatant was then acidified to pH 2.00 to
reduce the solubility of the siderophore for chromatography using an XAD-2 column.
Manual Column Chromatography
Amberlite XAD-2. The XAD-2 column was the first column used for purification. The
acidified supernatant was run through the column, and then the column was washed with ddH 20.
The filtrate and H20 wash were checked for siderophore on CAS to make sure that the
siderophore had bound in the column. If the CAS assay was negative, elution of the column with
methanol followed. Fifty fractions of approximately 3mL each were collected. Every other
fraction was tested on CAS media for siderophore activity, and those testing positive were
pooled and concentrated by evaporation for further purification. Depending on the flow rate of
the column, the positive fractions were generally in the range of fractions 15-30 and had a
brownish-red color.
Sephadex LH-20. The positive samples were further purified using an LH-20 column.
The evaporated, post-XAD sample was dissolved in pH 2.00 ddH20 and loaded on the LH-20
column. The column was run with ddh20 as the solvent and approximately 40 fractions were
taken. These fractions were checked on CAS for siderophore activity, and the positive fractions

41

were pooled and evaporated. Depending on flow rate the positive fractions were generally in the
range of fractions 15-25, and had a reddish color.
HPLC
After manual column chromatography the sample was further purified by high pressure
liquid chromatography (HPLC). A Watters C-18 column was used, and an appropriate solvent
system had to be found. A water/methanol system was attempted first, but the sample was highly
hydrophilic so it did not work. Then a system of 0.1% trifluoroacetic acid (TFA) as solvent A
and 0.1% TFA/acetonitrile as solvent B was used, with success. The HPLC was run with this
solvent system over a gradient of 1-100% solvent B, and the fractions collected and tested on
CAS. Two fractions tested positive, and based on the HPLC profile it was somewhere between
20-40% solvent B. Subsequent HPLC runs were made, further refining the gradient until it was
determined that the siderophore eluted at 23% solvent B. This percentage of solvent B correlated
to a specific peak on the HPLC profile (Figure 5) Further HPLC runs were made with fresh
samples using the refined gradient until only a single peak was evident on the HPLC profile,
indicating the elution of a possibly pure compound. The fraction corresponding to the peak was
collected, tested on CAS, dried, and saved for chemical and structural characterization
experiments.
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Figure 5: HPLC profile of H372 showing a single peak, indicating a pure siderophore

Siderophore Characterization
Atkin’s and Arnow’s Tests
After determining that H372 produced a siderophore, the next step was to characterize the
siderophore. The Arnow’s test was performed to determine if catechol species were present, and
the Atkins’ test was performed to determine if hydroxamate species were present. Both tests
indicate a positive result if the sample turns red or has a spectrophotomer reading of 0.003 or
greater. The Arnow’s test was negative with no color change and a reading of -0.008. The
Atkin’s test was negative with no color change and a reading of 0.001. The negative results of
these tests indicated that the siderophore did not belong to the common hydroxamate or catechol
types. If a siderophore is not a hydroxamate or catechol type, the default category is carboxylate.
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Amino Acid Analysis
Many siderophores are conjugates of amino acids, so amino acid analysis was performed
on the sample to determine the amino acids present. The sample was acid hydrolyzed and spotted
on a TLC plate alongside amino acid standards. The TLC plate was developed in solvent and
sprayed with ninhydrin reagent to reveal the spots. The hydrolyzed sample showed the presence
of 3 products indicated by 3 spots (Figure 6). Spot 1 had the same Rf value as ornithine. Spot 2
had the closest Rf value to tryptophan but was close to phenylalanine and isoleucine as well
(Figure 7). Spot 3 had a higher Rf value than any of the amino acids possibly indicating some
sort of degradative product that reacted with the ninhydrin but not an amino acid.
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Figure 6: Amino Acid Analysis with the sample and ornithine
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Figure 7: Amino Acid Analysis with the sample and 20 amino acids
A-alanine, R-arginine, N-asparagine, D-aspartic acid, C-cysteine, E-glutamic acid, Q-glutamine,
G-glycine, H-histidine, I-isoleucine, L-leucine, K-lysine, M-methionine, F-phenylalanine, Pproline, S-serine, T-threonine, W-tryptophan, V-valine
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ESMS
Electron spray mass spectrometry (ESMS) was performed by the Analytical Division of
Eastman Chemical for the molecular weight and possible structural elucidation of the sample. A
regular sample and an iron-complexed sample were provided. Unfortunately, the iron-complexed
sample did not yield any useful data. The reason for this is unknown.
Figure 8 shows an HPLC profile of the sample. While the HPLC performed at the ETSU
lab showed a single peak, this HPLC showed 14 peaks. This difference may be explained by the
use of a different solvent system. The peak with the largest area under the curve corresponds to
the major product, and this is peak 8. The assumption is that because the purification process was
designed to isolate a siderophore, the major product will indeed be the siderophore; however, it
is possible that is not the case. Because the mixture was complex, we did not get useful structural
information to confirm the likelihood of a siderophore.
After HPLC the fraction corresponding to each peak was analyzed by ESMS for
molecular weight data. The ESMS was perfomed at 10v, -25v, +25v, -75v, and 75v (Figures 813). The 10v setting’s function is to ascertain an accurate mass as the molecules will not break
apart at that voltage. The mass at the 10v setting appears to be 681 kDa (Figure 9). However, the
mass at the 25v setting is 658 (Figure 10). This difference is likely explained by a sodium
adduct. Sodium adducts are common in ESMS analysis and they add 23 kDa to the molecular
weight. A sodium adduct is also present in the 75v data (Figure 12). The 25v and 75v settings
can be used for structural information as fragmentation of the molecule can occur. Some
fragmentation did occur at +75v as the peak at 681 kDa (molecular weight + sodium) is smaller
and a new, high peak is seen at 245 kDa.
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Figure 8: Eastman Chemical HPLC data for strain H372 showing 14 peaks

Figure 9: 10v accurate mass data for H372 sample peak 8
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Figure 10: ESMS data at +25v

Figure 11:ESMS data at -25v

Figure 12: ESMS data at +75v
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Figure 13: ESMS data at -75v
Based on the molecular weight and the combination of the elements carbon, hydrogen,
oxygen, and nitrogen, the ESMS machine produced possible molecular formulas for the major
product of the sample (Table 5). The formulas were then entered into the SciFinder database to
see if they corresponded to any known siderophores. No corresponding siderophores were found.
This could indicate a completely new siderophore or that the major product is not a siderophore.
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Table 5: ESMS elemental composition report (first 12 results, ranked by similarity to sample)
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NMR
Nuclear magnetic resonance (NMR) was also performed by the Analytical Division at
Eastman Chemical. The NMR also shows a very complex mixture in the sample (Figure 14).
Due to the number of peaks it is difficult to glean useful information from this NMR result. The
only definitive bonds that can be observed are CH2 bonds (circled in green) and an aromatic ring
(circled in purple). CH2 bonds are extremely common, so they would be expected in almost any
NMR analysis. The source of the aromatic rings is unknown.

Figure 14: NMR Data. CH2 bonds circled in green, Aromatic ring bonds circled in purple.
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CHAPTER 4
DISCUSSION
The vast majority of organisms need iron to survive, and most bacteria produce
siderophores for this purpose. Siderophores are known to be important in the pathogenesis of
bacteria including S. aureus (24). However, most siderophore research focuses on Gram negative
bacteria. Much less is known about siderophores produced by Gram-positive bacteria including
siderophores of staphylococci. Staphylococci produce 4 known siderophores: staphyloferrin A,
staphyloferrin B, staphylobactin, and aureochelin. Only the staphyloferrins have been fully
characterized; the structures of staphylobactin and aureochelin remain unknown (22, 29, 42).
Due to the importance of siderophores to virulence, there is a need to know more about the
siderophores of S. aureus.
The purpose of this research was to identify and characterize siderophores in S. aureus,
particularly in antibiotic-resistant strains. Because iron acquisition could be a drug target, it is
important to learn more about these systems in S. aureus. In the United States alone 94,000
people a year contract invasive MRSA infections and 19,000 people die of MRSA annually (16).
In our lab numerous strains of MRSA were tested for siderophore activity, and those possessing
the greatest siderophore activity were selected for further study. Of those strain H372 was
selected due to its strong production. After selecting this strain siderophore production needed to
be optimized and the siderophore characterized.
Due to the intrinsically low iron requirement of S. aureus (56), it was difficult to find a
growth medium with sufficient iron restriction. The medium that best supported growth and
siderophore production was LB Broth with 500μm dipyridyl to sequester iron. Minimal medias
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such as Fiss, TMS, Congo Red, and MMW were tried, but either growth or siderophore
production were compromised.
After optimization of production purification methods were followed based on the
preliminary chemical characterization of the siderophore. The Arnow’s test for catechol
siderophores and the Atkin’s test for hydroxamate siderophores were performed. The
siderophore from H372 tested negative, indicating it is neither a catechol nor hydroxamate type.
Based on the data we presume it is a carboxylate type siderophore, although there is no definitive
test for this type. This finding was consistent with the fact that staphyloferrin A and B are both
carboxylate siderophores. Based on the presumption that it is a carboxylate siderophore, we tried
to use the published procedures for the purification of the staphyloferrins.
After determining the optimum conditions and type of siderophore, large batch cultures
were needed for purification. Purification involved 3 chromatographic processes. First, the
acidified supernatant was passed through an amberlite XAD-2 column that binds cyclic
molecules. The CAS-positive fractions from the XAD-2 were then pooled and concentrated.
Second, the concentrated CAS positive material was passed through a sephadex LH-20 column
that separates molecules according to size and hydrophobicity. The CAS positive fractions from
the Sephadex LH-20 were then pooled and concentrated. Third, the concentrated CAS positive
sample from the sephdex LH-20 column was analyzed with HPLC using a Waters C-18 column.
The CAS assay was used to follow the siderophore throughout the process. The first HPLC
solvent system tried was a water/methanol system; however, the siderophore was highly
hydrophilic and eluted in the water immediately. This hydrophilicity is consistent with
staphyloferrin A, so the system was changed to the TFA/TFA-acetonitrile that was used during
the purification of staphyloferrin A (52). The high hydrophilicity of the siderophore is also why
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thin-layer chromatography (TLC) of the siderophore was never satisfactory. The silica gel plates
and solvent systems used for TLC were too hydrophobic and the hydrophilic siderophore
samples did not migrate up the plate. The new solvent system for HPLC worked, and it was
determined that the siderophore corresponded to a specific peak on the HPLC profile that eluted
at 23% solvent B. This HPLC profile was significantly different than staphyloferrin A, which
elutes at between 4-10% of solvent B using the same solvent system (52). When this single peak
was evident on the HPLC profile, the sample was considered pure.
Siderophores are usually conjugates of amino acids, so amino acid analysis was
performed on the sample. The sample was acid-hydrolyzed, spotted on TLC plates, and
compared to the 20 amino acids and ornithine. The sample showed 3 spots on TLC. The lowest
spot, designated as spot 1, had the Rf value of ornithine. Spot 2 had the closest Rf value to
tryptophan, although it was close to phenylalanine and isoleucine as well. Spot 3 was higher than
all the Rf values for the amino acids, so it is presumably a degradative product that reacted with
the ninhydrin reagent. The presence of ornithine was intriguing because both staphyloferrin A
and B contain ornithine.
The HPLC purified samples were analyzed by ESMS and NMR to attempt to discern
structural information and molecular weight. Both an iron-complexed and a non iron-complexed
sample were analyzed. Unfortunately, the iron-complexed sample did not yield any useful data
for unknown reasons. Although the ESMS profile shows multiple peaks, the probable molecular
weight based on the major peak is 658, which is significantly different than staphyloferrin A at
481 Da (61), staphyloferrin B at 448 Da (42), staphylobactin at 822 Da (24), or aureochelin at
577 Da (22). The molecular weight data suggest that this siderophore may not be any of the
known staphylococcal siderophores. The ESMS data were also analyzed using a molecular mass
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database for known compounds but no matches were found, even when specifically searching for
siderophores.
The NMR data suggested the presence of CH2 bonds and an aromatic ring. The CH2
bonds are too common to assist in identification of the structure of the siderophore.
The final conclusion of this research is that S. aureus strain H372 produces a hydrophilic
siderophore that contains ornithine and has a probable molecular weight of 658. The siderophore
could be novel or it could be that one of the staphyloferrins is present and bound to other
molecules increasing its molecular weight.
Future studies for this project include further structural elucidation of this siderophore.
Although the siderophore appeared pure on HPLC, the complex profiles of the ESMS and NMR
indicate either that the purity needs to be improved or that the siderophore is degrading during
the process of purification or storage after purification. The identification and structural
determination of this siderophore can be helpful in the study of its regulation, biosynthesis, and
transport.
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